Open AccessEfficacy of rituximab in gastric diffuse large B cell lymphoma patients
Author(s) -
Davide Leopardo,
Giuseppe Di Lorenzo,
Amalia De Renzo,
Piera Federico,
Serena Luponio,
Carlo Buonerba,
Elide Matano,
G. Merola,
Martina Imbimbo,
E. Montesarchio,
Antonio Rea,
Maria Carmela Merola,
Sabino De Placido,
Giovannella Palmieri
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i20.2526
Subject(s) - rituximab , medicine , vincristine , chop , cyclophosphamide , chemotherapy , gastroenterology , diffuse large b cell lymphoma , prednisone , lymphoma , clinical endpoint , group b , surgery , survival rate , oncology , randomized controlled trial
To evaluate retrospectively the efficacy of rituximab plus chemotherapy in gastric diffuse large B cell lymphoma (DLBCL).